The secretion of IL-6 is further significant in AIDS-NHL because it may render the tumor cells resistant to the cytotoxic effects of chemotherapeutic drugs and/or increase the side effects [10,18,19]. Here, IL6 is linked to non-Hodgkin lymphoma.